WallStreetZenWallStreetZen

NASDAQ: TRDA
Entrada Therapeutics Inc Stock Ownership - Who owns Entrada Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Entrada Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Peter S. KimDirector2024-04-082,600$13.57
$35.29kBuy
Peter S. KimDirector2024-03-281,512$13.75
$20.79kBuy
Peter S. KimDirector2024-03-262,750$13.64
$37.51kBuy
Peter S. KimDirector2024-03-253,180$13.36
$42.47kBuy
Peter S. KimDirector2024-03-223,118$13.76
$42.90kBuy
Peter S. KimDirector2024-03-21704$13.24
$9.32kBuy
Peter S. KimDirector2024-03-201,128$12.66
$14.28kBuy
Peter S. KimDirector2024-03-19900$12.66
$11.40kBuy
Kory James WentworthChief Financial Officer2024-03-159,000$2.10
$18.90kBuy
Nathan J. DowdenPresident COO2024-03-061,826$12.32
$22.50kSell

1 of 7

TRDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRDA insiders and whales buy or sell their stock.

TRDA Shareholders

What type of owners hold Entrada Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP14.48%4,865,819$57.66MInstitution
Baker Bros Advisors LP13.40%4,501,658$53.34MInsider
Todd Foley13.17%4,425,784$52.45MInsider
Mpm Bioventures 2014 LP13.17%4,425,784$52.45MInsider
Mpm Bioventures 2018 LP13.17%4,425,784$52.45MInsider
Mpm Asset Management LLC13.17%4,425,784$52.45MInstitution
5am Venture Management LLC13.12%4,408,379$52.24MInstitution
Price T Rowe Associates Inc8.96%3,009,673$35.66MInstitution
Roche Holding Ltd8.37%2,813,525$33.34MInsider
Redmile Group LLC5.82%1,954,420$23.16MInsider

1 of 3

TRDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRDA50.54%49.46%Net SellingNet Buying
EDIT64.04%35.96%Net SellingNet Selling
MREO11.20%4.59%
CCCC68.39%25.32%Net BuyingNet Selling
PEPG50.08%18.34%Net BuyingNet Buying
View Top Biotech Stocks

Entrada Therapeutics Stock Ownership FAQ

Who owns Entrada Therapeutics?

Entrada Therapeutics (NASDAQ: TRDA) is owned by 78.22% institutional shareholders, 76.55% Entrada Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Entrada Therapeutics shareholder, owning 4.50M shares representing 13.40% of the company. Baker Bros Advisors LP's Entrada Therapeutics shares are currently valued at $59.65M.

If you're new to stock investing, here's how to buy Entrada Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.